Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: evidence of predictable and reproducible patterns of synergy in diverse neoplasms
- 30 April 2004
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 14 (2) , 81-91
- https://doi.org/10.1016/j.semcancer.2003.09.013
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Tumor Suppressor p53 Mediates Apoptotic Cell Death Triggered by Cyclosporin APublished by Elsevier ,2002
- p53 protein oxidation in cultured cells in response to pyrrolidine dithiocarbamate: a novel method for relating the amount of p53 oxidation in vivo to the regulation of p53-responsive genesBiochemical Journal, 2000
- Skin cancer in liver transplant recipientsLiver Transplantation, 2000
- MDM-2 Oncoprotein Overexpression, p53 Gene Mutation, and VEGF Up-Regulation in AngiosarcomasThe American Journal of Pathology, 1998
- AP-2 may contribute to IGF-II overexpression in rhabdomyosarcomaOncogene, 1998
- Redox Modulation of AP-2 DNA Binding Activityin VitroBiochemical and Biophysical Research Communications, 1998
- ATF2 confers radiation resistance to human melanoma cellsOncogene, 1998
- A target for phosphoinositide 3-kinase: Akt/PKBTrends in Biochemical Sciences, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993